Business Context and Reporting Period
Company: 180 Life Sciences Corp. (trading symbol: ATNF; formerly Forum Markets Inc. in request metadata, but filing identifies 180 Life Sciences Corp.)
Reporting Period: Quarter ended March 31, 2025 (Form 10-Q)
Business Overview: The Company is transitioning from a clinical-stage biotechnology firm to an online iGaming operator. In September 2024, it acquired a blockchain-based "Gaming Technology Platform" from Elray Resources, Inc. Legacy biotechnology assets (fibrosis/anti-TNF and CBD derivatives) are in care and maintenance mode, with the alpha 7 nicotinic acetylcholine receptor program returned to Stanford University in November 2024. The Company has no current revenue and is evaluating strategic options for its biotech assets.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(2,369,232) | $(1,069,744) |
| Operating Expenses | $2,372,968 | $2,092,468 |
| Cash and Cash Equivalents (End of Period) | $3,724,527 | $675,977 |
| Working Capital | $86,956 | $(1,636,486) |
| Total Assets | $11,650,794 | $12,763,412 |
| Total Liabilities | $3,945,222 | $3,511,501 |
| Stockholders' Equity | $7,705,572 | $(954,466) |
| Cash Used in Operating Activities | $(853,723) | $(1,033,417) |
Note: The filing text does not provide explicit margin percentages as there is no revenue. The Company reported a net loss per share of $(0.67) for Q1 2025.
Material Changes vs. Prior Period
- Net Loss Increase: Net loss increased by 121% to $2.37 million, driven primarily by a $440,000 increase in General and Administrative (G&A) expenses. This increase was due to higher stock-based compensation ($343,000) and legal fees ($410,000) related to settlements, partially offset by reduced salaries and insurance costs.
- Other Income Decline: Other income dropped from $1.04 million in Q1 2024 to $6,391 in Q1 2025. The prior year included a one-time gain of $1.04 million from the forgiveness of contractor liabilities.
- Equity Position: Stockholders' equity improved from a deficit of $(954,466) in Q1 2024 to a positive $7.7 million in Q1 2025. This was largely due to the conversion of Series B Convertible Preferred Stock into common stock and the issuance of shares for services and settlements.
- Intangible Assets: Intangible assets remained flat at $7.6 million, representing the acquired Gaming Technology Platform which is not yet amortized as it is not in service.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern: The Company has raised substantial doubt about its ability to continue as a going concern. With a monthly cash burn of approximately $252,000 and no revenue, management estimates current cash will last only until December 2025. Significant additional capital is required to commercialize the iGaming platform and settle debts.
- Strategic Pivot: The Company is shifting focus entirely to the iGaming sector. Commercialization of the blockchain casino platform is estimated to cost between $3 million and $5 million, requiring a front-end interface, game content, and regulatory licensing.
- Recent Settlements (Subsequent Events):
- AmTrust: Settled D&O insurance litigation for $250,000 cash and 509,707 shares of common stock (valued at $575,000).
- Elray/Luxor: Entered a settlement to repurchase 1,318,000 shares (23.1% of outstanding) held by Elray for $1 million ($350k cash, $650k payable from future capital raises).
- Dr. Krauss: Settled litigation with former CEO for $50,000 cash and 200,000 shares.
- Nasdaq Compliance: The Company regained compliance with Nasdaq's stockholders' equity rule in October 2024 but is subject to a one-year mandatory panel monitor. Failure to maintain compliance could result in delisting.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2025, citing a material weakness in financial reporting review processes.
Investor Verification Checklist
- Cash Runway: Verify the accuracy of the $252,000 monthly burn rate and the December 2025 liquidity horizon given the lack of revenue.
- Debt Obligations: Confirm the status of the approximately $1.3 million owed to the University of Oxford, which has threatened legal action and wind-up petitions.
- Share Repurchase Terms: Review the terms of the $1 million settlement with Elray, specifically the $650,000 portion payable from future capital raises, which could dilute existing shareholders or restrict future fundraising.
- iGaming Viability: Assess the feasibility of raising the estimated $3M-$5M required to launch the casino platform and obtain necessary gaming licenses.
- Internal Controls: Monitor the remediation plan for the material weakness in internal controls over financial reporting.